Cervical Cancer Screening Recommendations (2018)

US Preventive Services Task Force

Reviewed and summarized by Medscape editors

September 14, 2018

The recommendations on cervical cancer screening were released on August 21, 2018, by the USPSTF.[1,2]

The USPSTF recommends screening for cervical cancer every 3 years, with cervical cytology alone for women who are 21 to 29 years of age.

For women who are 30 to 65 years of age, the USPSTF recommends screening every 3 years with cervical cytology alone, every 5 years with high-risk human papillomavirus (hrHPV) testing alone, or every 5 years with hrHPV testing in combination with cytology (cotesting).

Screening in women who are older than 65 years is not recommended if they have had adequate prior screening and are not at high risk for cervical cancer.

The USPSTF recommends against screening for cervical cancer in women who are younger than 21 years.

The USPSTF recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and who do not have a history of high-grade precancerous lesions (ie, cervical intraepithelial neoplasia grade 2 or 3) or cervical cancer.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.